925 followers
New article: Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells. https://t.co/9BQs4ewDG6 #AML #leusm #hematology
New article: Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells. https://t.co/9BQs4ewDG6 #AML #leusm #hematology